FibroBiologics, Inc. (FBLG)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.39+$0.0300 (+2.21%) on the dayAs of the close; data may be delayed.
FBLG price, last 12 months
Key stats
- Previous close
- $1.36
- Open
- $1.35
- Day range
- $1.33 – $1.39
- 52-week range
- $0.6200 – $12.40
- Volume
- 55.4K
- Avg volume (20 days)
- 261.4K
- Market cap
- $9.7M
Performance
1W−2.8%
1M−1.4%
3M+68.3%
6M−68.4%
YTD−69.1%
1Y−88.5%
vs S&P 500, 1Y−105.2 pts
Technicals and fundamentals
About FibroBiologics, Inc.
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $9.7M